- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 59/42 - Composés non saturés contenant des groupes hydroxyle ou O-métal
Détention brevets de la classe C07C 59/42
Brevets de cette classe: 111
Historique des publications depuis 10 ans
|
7
|
11
|
10
|
7
|
8
|
6
|
1
|
5
|
7
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Brigham and Women's Hospital, Inc. | 2282 |
9 |
| University of Southern California | 2128 |
8 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 823 |
6 |
| Thetis Pharmaceuticals LLC | 23 |
6 |
| Universitat de les Illes Balears | 75 |
4 |
| University Health Network | 1061 |
4 |
| DS Biopharma Limited | 24 |
4 |
| Noster Inc. | 68 |
4 |
| The Regents of the University of California | 20720 |
3 |
| Board of Regents, The University of Texas System | 6102 |
3 |
| New York Medical College | 43 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
3 |
| Topsoe A/S | 1044 |
3 |
| Dignity Sciences Limited | 15 |
2 |
| Ecover Co-ordination Center N.V. | 7 |
2 |
| Lipopharma Therapeutics, S.L. | 8 |
2 |
| Marrone Bio Innovations, Inc. | 101 |
2 |
| Pierre Fabre Dermo-Cosmetique | 361 |
2 |
| The University of British Columbia | 1537 |
2 |
| The University of Tokyo | 4352 |
2 |
| Autres propriétaires | 37 |